A

Arctic Bioscience AS
OSE:ABS

Watchlist Manager
Arctic Bioscience AS
OSE:ABS
Watchlist
Price: 3.49 NOK -1.69% Market Closed
Market Cap: 93.7m NOK

Relative Value

The Relative Value of one ABS stock under the Base Case scenario is hidden NOK. Compared to the current market price of 3.49 NOK, Arctic Bioscience AS is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ABS Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
64
vs Industry
Median 3Y
6.2
Median 5Y
6.2
Industry
8.2
Forward
1.2
vs History
vs Industry
Median 3Y
-5.5
Median 5Y
-6.5
Industry
24.2
Forward
17.3
vs History
vs Industry
Median 3Y
-8.3
Median 5Y
-27.9
Industry
23
vs History
vs Industry
Median 3Y
-3.8
Median 5Y
-5.8
Industry
25.5
vs History
81
vs Industry
Median 3Y
0.9
Median 5Y
1
Industry
3.3
vs History
61
vs Industry
Median 3Y
3.2
Median 5Y
3.2
Industry
8.6
Forward
1.4
vs History
54
vs Industry
Median 3Y
9.6
Median 5Y
9.6
Industry
10.5
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-3.7
Industry
6.1
Forward
27.8
vs History
vs Industry
Median 3Y
-3
Median 5Y
-3.5
Industry
6.6
Forward
-27.8
vs History
vs Industry
Median 3Y
-5.4
Median 5Y
-14.8
Industry
8.8
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-131.5
Industry
6.8
vs History
79
vs Industry
Median 3Y
0.7
Median 5Y
0.8
Industry
5.7

Multiples Across Competitors

ABS Competitors Multiples
Arctic Bioscience AS Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NO
Arctic Bioscience AS
OSE:ABS
93.7m NOK 2.1 -2.2 -3.2 -2.8
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 170 980.7 -162 409.6 -197 217.1 -194 966.6
US
Abbvie Inc
NYSE:ABBV
379.8B USD 6.4 161.8 15.8 22.4
US
Amgen Inc
NASDAQ:AMGN
176.7B USD 4.9 25.2 18.2 18.2
US
Gilead Sciences Inc
NASDAQ:GILD
153.3B USD 5.3 18.9 12.7 12.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.7B USD 9.6 30.7 22.5 23.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 061.7 -526.1 -572.9 -557.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.6B USD 5.4 16.9 16.1 18.3
AU
CSL Ltd
ASX:CSL
85B AUD 3.7 19 12.8 16
NL
argenx SE
XBRU:ARGX
43.3B EUR 13.9 32.8 56.4 58
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.8B USD 14.9 1 097.1 147.8 179.3
P/E Multiple
Earnings Growth PEG
NO
A
Arctic Bioscience AS
OSE:ABS
Average P/E: 175.3
Negative Multiple: -2.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -162 409.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
161.8
89%
1.8
US
Amgen Inc
NASDAQ:AMGN
25.2
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.9
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.7
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -526.1 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.9
10%
1.7
AU
CSL Ltd
ASX:CSL
19
11%
1.7
NL
argenx SE
XBRU:ARGX
32.8
40%
0.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 097.1
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
NO
A
Arctic Bioscience AS
OSE:ABS
Average EV/EBITDA: 37.8
Negative Multiple: -3.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 217.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.8
14%
1.1
US
Amgen Inc
NASDAQ:AMGN
18.2
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.7
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.5
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -572.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.1
11%
1.5
AU
CSL Ltd
ASX:CSL
12.8
8%
1.6
NL
argenx SE
XBRU:ARGX
56.4
810%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
147.8
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
NO
A
Arctic Bioscience AS
OSE:ABS
Average EV/EBIT: 43.5
Negative Multiple: -2.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 966.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.4
30%
0.7
US
Amgen Inc
NASDAQ:AMGN
18.2
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.7
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -557.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.3
13%
1.4
AU
CSL Ltd
ASX:CSL
16
11%
1.5
NL
argenx SE
XBRU:ARGX
58
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
179.3
N/A N/A